Ratings
0
Nobody has rated this yet. Be the first!
Works
3
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
